Jennifer Meunier, NP
Nurse Practitioner · Owensboro, KYNPI 1316422504
Payments from drug & device makers
Across 89 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$384
- Novo Nordisk$176
- Biogen$149
- Channel Medsystems, Inc.$119
- Currax Pharmaceuticals LLC$101
- Sumitomo Pharma America, Inc.$87
- plus $688 from 19 others
What the payments were for
- Food & beverage$1,64096%
- Education$644%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $384 |
| Novo Nordisk | 11 | $176 |
| Biogen | 6 | $149 |
| Channel Medsystems, Inc. | 1 | $119 |
| Currax Pharmaceuticals LLC | 6 | $101 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
| Hologic Sales And Service, LLC | 5 | $85 |
| Aspira Women's Health Inc | 1 | $68 |
| Exeltis, USA Inc. | 4 | $62 |
| Amgen | 4 | $59 |
| Organon | 3 | $57 |
| Pfizer | 4 | $49 |
| Agile Therapeutics, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $36 |
| Shield Therapeutics Inc | 2 | $34 |
| Mayne Pharma Commercial LLC | 2 | $32 |
| Lilly USA, LLC | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Gynesonics, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $15 |
| Urovant Sciences Inc | 1 | $14 |
| Axonics, Inc. | 1 | $13 |
| Endogastric Solutions, Inc | 1 | $13 |
How this compares
$1,704 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $297 |
| Rosuvastatin Calcium | 11 | $26 |
| Levothyroxine Sodium | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Owensboro
- Vanessa CoxOwensboro$10K
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.